Lv6
2020 积分 2023-10-19 加入
Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial
23天前
已完结
Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial
23天前
已完结
Asundexian or Apixaban in Patients With Atrial Fibrillation According to Prior Oral Anticoagulant Use
29天前
已关闭
Asundexian or Apixaban in Patients With Atrial Fibrillation According to Prior Oral Anticoagulant Use
1个月前
已完结
Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial
1个月前
已完结
Effects of GLP-1 agonists on proportion of weight loss in obesity with or without diabetes: Systematic review and meta-analysis
1个月前
已完结
Olpasiran, Oxidized Phospholipids, and Systemic Inflammatory Biomarkers
1个月前
已完结
Model‐Informed Approaches to Support Drug Development for Patients With Obesity: A Regulatory Perspective
2个月前
已完结
Randomized, Double‐Blind, Crossover, Clinical‐End‐Point Pilot Study to Examine the Use of Exhaled Nitric Oxide as a Bioassay for Dose Separation of Inhaled Fluticasone Propionate
2个月前
已完结
American Association of Clinical Endocrinology Clinical Practice Guideline on Pharmacologic Management of Adults With Dyslipidemia
2个月前
已关闭
皖公网安备34019202002308
